CXCR4 and prostate cancer: To further demonstrate how essential CXCR4 is to prostate cancer bone metastasis, the authors neutralized the receptor by injecting antibodies against CXCR4 and found that prostate-cancer-to-bone metastases were significantly inhibited [112].